✦ LIBER ✦

Goshajinkigan oxaliplatin neurotoxicity evaluation (GONE): a phase 2, multicenter, randomized, double-blind, placebo-controlled trial of goshajinkigan to prevent oxaliplatin-induced neuropathy

✍ Scribed by Kono, Toru; Hata, Taishi; Morita, Satoshi; Munemoto, Yoshinori; Matsui, Takanori; Kojima, Hiroshi; Takemoto, Hiroyoshi; Fukunaga, Mutsumi; Nagata, Naoki; Shimada, Mitsuo; Sakamoto, Junichi; Mishima, Hideyuki

Book ID: 121602464
Publisher: Springer
Year: 2013
Tongue: English
Weight: 228 KB
Volume: 72
Category: Article
ISSN: 0344-5704
DOI: 10.1007/s00280-013-2306-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

6089 POSTER Goshajinkigan (TJ-107) for O

6089 POSTER Goshajinkigan (TJ-107) for Oxaliplatin-induced Sensory Neurotoxicity in Colorectal Cancer Patients – a Prospective, Randomized, Double-blinded, Placebo-controlled, Phase II Trial (GONE)

✍ Matsui, T.; Kono, T.; Hata, T.; Fukunaga, M.; Munemoto, Y.; Nagata, N.; Shimada, 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 44 KB

Phase III Randomized, Placebo-Controlled

Phase III Randomized, Placebo-Controlled, Double-Blind Study of Intravenous Calcium and Magnesium to Prevent Oxaliplatin-Induced Sensory Neurotoxicity (N08CB/Alliance)

✍ Loprinzi, C. L.; Qin, R.; Dakhil, S. R.; Fehrenbacher, L.; Flynn, K. A.; Atherto 📂 Article 📅 2014 🏛 American Society of Clinical Oncology 🌐 English ⚖ 224 KB